医学
内科学
肺癌
单中心
回顾性队列研究
化疗
吉西他滨
肿瘤科
队列
封锁
受体
作者
Sheng Xu,Yuanming Li,Zhixin Bie,Xiaoguang Li
摘要
Compared with DEB-BACE/BAI, PD-1 blockade plus DEB-BACE/BAI could improve the prognosis for advanced NSCLC despite the associated risk of grade 3 irAEs. The combination regimens are promising and safe approaches for advanced NSCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI